Recent progress of nanotechnology-based theranostic systems in cancer treatments
Theranostics that integrates therapy and diagnosis in one system to achieve accurate cancer diagnosis and treatment has attracted tremendous interest, and has been recognized as a potential breakthrough in overcoming the challenges of conventional oncotherapy. Nanoparticles are ideal candidates as c...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
China Anti-Cancer Association
2021-05-01
|
Series: | Cancer Biology & Medicine |
Subjects: | |
Online Access: | http://www.cancerbiomed.org/index.php/cocr/article/view/1839 |
id |
doaj-6de88393fadd4008a08e62c068be229d |
---|---|
record_format |
Article |
spelling |
doaj-6de88393fadd4008a08e62c068be229d2021-06-15T08:54:59ZengChina Anti-Cancer AssociationCancer Biology & Medicine2095-39412021-05-0118233635110.20892/j.issn.2095-3941.2020.0510Recent progress of nanotechnology-based theranostic systems in cancer treatmentsYing Xue0Yuting Gao1Fanling Meng2Liang Luo3National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, ChinaNational Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, ChinaNational Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, ChinaNational Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, ChinaTheranostics that integrates therapy and diagnosis in one system to achieve accurate cancer diagnosis and treatment has attracted tremendous interest, and has been recognized as a potential breakthrough in overcoming the challenges of conventional oncotherapy. Nanoparticles are ideal candidates as carriers for theranostic agents, which is attributed to their extraordinary physicochemical properties, including nanoscale sizes, functional properties, prolonged blood circulation, active or passive tumor targeting, specific cellular uptake, and in some cases, excellent optical properties that ideally meet the needs of phototherapy and imaging at the same time. Overall, with the development of nanotechnology, theranostics has become a reality, and is now in the transition stage of “bench to bedside.” In this review, we summarize recent progress on nanotechnology-based theranostics, i.e., nanotheranostics, that has greatly assisted traditional therapies, and has provided therapeutic strategies emerging in recent decades, as well as “cocktail” theranostics mixing various treatment modalities.http://www.cancerbiomed.org/index.php/cocr/article/view/1839theranosticscancer therapydiagnosisnanoparticlesnanotechnology |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ying Xue Yuting Gao Fanling Meng Liang Luo |
spellingShingle |
Ying Xue Yuting Gao Fanling Meng Liang Luo Recent progress of nanotechnology-based theranostic systems in cancer treatments Cancer Biology & Medicine theranostics cancer therapy diagnosis nanoparticles nanotechnology |
author_facet |
Ying Xue Yuting Gao Fanling Meng Liang Luo |
author_sort |
Ying Xue |
title |
Recent progress of nanotechnology-based theranostic systems in cancer treatments |
title_short |
Recent progress of nanotechnology-based theranostic systems in cancer treatments |
title_full |
Recent progress of nanotechnology-based theranostic systems in cancer treatments |
title_fullStr |
Recent progress of nanotechnology-based theranostic systems in cancer treatments |
title_full_unstemmed |
Recent progress of nanotechnology-based theranostic systems in cancer treatments |
title_sort |
recent progress of nanotechnology-based theranostic systems in cancer treatments |
publisher |
China Anti-Cancer Association |
series |
Cancer Biology & Medicine |
issn |
2095-3941 |
publishDate |
2021-05-01 |
description |
Theranostics that integrates therapy and diagnosis in one system to achieve accurate cancer diagnosis and treatment has attracted tremendous interest, and has been recognized as a potential breakthrough in overcoming the challenges of conventional oncotherapy. Nanoparticles are ideal candidates as carriers for theranostic agents, which is attributed to their extraordinary physicochemical properties, including nanoscale sizes, functional properties, prolonged blood circulation, active or passive tumor targeting, specific cellular uptake, and in some cases, excellent optical properties that ideally meet the needs of phototherapy and imaging at the same time. Overall, with the development of nanotechnology, theranostics has become a reality, and is now in the transition stage of “bench to bedside.” In this review, we summarize recent progress on nanotechnology-based theranostics, i.e., nanotheranostics, that has greatly assisted traditional therapies, and has provided therapeutic strategies emerging in recent decades, as well as “cocktail” theranostics mixing various treatment modalities. |
topic |
theranostics cancer therapy diagnosis nanoparticles nanotechnology |
url |
http://www.cancerbiomed.org/index.php/cocr/article/view/1839 |
work_keys_str_mv |
AT yingxue recentprogressofnanotechnologybasedtheranosticsystemsincancertreatments AT yutinggao recentprogressofnanotechnologybasedtheranosticsystemsincancertreatments AT fanlingmeng recentprogressofnanotechnologybasedtheranosticsystemsincancertreatments AT liangluo recentprogressofnanotechnologybasedtheranosticsystemsincancertreatments |
_version_ |
1721376602360643584 |